It is, therefore, possible that EGCG may be a dietary antioxidant that can be used clinically in PD patients to inhibit COMT-mediated metabolic disposition of L-DOPA while also exerting neuroprotective actions. This evidence concerns the gene COMT and Parkinson disease.